PMDA drug package insert

ダルベポエチン アルファBS注5μgシリンジ「三和」

PMDA Prescription drug · 株式会社三和化学研究所 · package insert Jun 17, 2025

Key facts

Brand names ダルベポエチン アルファBS注5μgシリンジ「三和」, ダルベポエチン アルファBS注10μgシリンジ「三和」, ダルベポエチン アルファBS注15μgシリンジ「三和」, ダルベポエチン アルファBS注20μgシリンジ「三和」, ダルベポエチン アルファBS注30μgシリンジ「三和」, ダルベポエチン アルファBS注40μgシリンジ「三和」, ダルベポエチン アルファBS注60μgシリンジ「三和」, ダルベポエチン アルファBS注120μgシリンジ「三和」, ダルベポエチン アルファBS注180μgシリンジ「三和」
Nonproprietary names ダルベポエチン アルファ(遺伝子組換え)
Companies 製造販売(輸入)元/株式会社三和化学研究所
Product type Prescription drug
Therapeutic category 持続型赤血球造血刺激因子製剤
Therapeutic category codes 873999
YJ codes 3999454G1026, 3999454G2022, 3999454G3029, 3999454G4025, 3999454G5021, 3999454G6028, 3999454G7024, 3999454G8020, 3999454G9027
Approval numbers 30100AMX00262000, 30100AMX00263000, 30100AMX00264000, 30100AMX00265000, 30100AMX00266000, 30100AMX00267000, 30100AMX00268000, 30100AMX00269000, 30100AMX00270000
Package insert edition 第3版
Package insert date Jun 17, 2025
PMDA document key 300297_3999454G1026_1
PMDA company code 300297

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • Yes PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)